Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.

Detalles Bibliográficos
Publicado en:British Journal of Cancer Vol. 114; no. 12; pp. 1395 - 1405
Autores principales: Meseure, Didier, Vacher, Sophie, Lallemand, François, Alsibai, Kinan Drak, Hatem, Rana, Chemlali, Walid, Nicolas, Andre, De Koning, Leanne, Pasmant, Eric, Callens, Celine, Lidereau, Rosette, Morillon, Antonin, Bieche, Ivan
Formato: research Journal Article
Publicado: Springer Nature 6/14/2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116145345&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 116145345
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00070920
        1XV
      jtl: British Journal of Cancer
      issn: 00070920
      maglogo: Y
    pubinfo:
      dt: 6/14/2016
      vid: 114
      iid: 12
      pid: 2579
      pub: Springer Nature
      place: Dordrecht, <Blank>
    artinfo:
      ui:
        116145345
        116145345
        NLM27172249
        116145345
        10.1038/bjc.2016.123
        NLM27172249
        PMC4984455
        116145345
      ppf: 1395
      ppct: 10
      formats:
      tig:
        atl: Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.
      aug:
        au:
          Meseure, Didier
          Vacher, Sophie
          Lallemand, François
          Alsibai, Kinan Drak
          Hatem, Rana
          Chemlali, Walid
          Nicolas, Andre
          De Koning, Leanne
          Pasmant, Eric
          Callens, Celine
          Lidereau, Rosette
          Morillon, Antonin
          Bieche, Ivan
          Lallemand, François
        affil: Department of Genetics, Unit of Pharmacogenetics, Institut Curie, 26 rue d'Ulm, Paris Cedex F-75248, France
      sug:
        subj:
          Breast Neoplasms
          RNA
          Prognosis
          Aged
          Epigenomics
          RNA Metabolism
          Cell Physiology
          Adult
          Female
          Aged, 80 and Over
          Breast Neoplasms Metabolism
          Breast Neoplasms Pathology
          Middle Age
          Human
          Aged: 65+ years
          Adult: 19-44 years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N